The impact of COVID-19 on antidepressant sales and prescription dispensing in Australia.

Tscharke, Ben J; Hollingworth, Samantha; van Driel, Mieke L; O'Brien, Jake W; Thai, Phong K

Tscharke, Ben J; Hollingworth, Samantha; van Driel, Mieke L; O'Brien, Jake W; Thai, Phong K.

Afiliação

Tscharke BJ; Queensland Alliance for Environmental Health Sciences, The University of Queensland, Woolloongabba, QLD, Australia.
Hollingworth S; School of Pharmacy, The University of Queensland, Woolloongabba, QLD, Australia.
van Driel ML; Primary Care Clinical Unit, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia.
O'Brien JW; Queensland Alliance for Environmental Health Sciences, The University of Queensland, Woolloongabba, QLD, Australia.
Thai PK; Queensland Alliance for Environmental Health Sciences, The University of Queensland, Woolloongabba, QLD, Australia.

Aust N Z J Psychiatry ; 56(7): 871-872, 2022 07.

Article em En | MEDLINE | ID: mdl-34963328

Assuntos

COVID-19; Antidepressivos/uso terapêutico; Austrália/epidemiologia; Prescrições de Medicamentos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google